ReviewDiagnostics (Basel, Switzerland)2022
Practical Approach to the Diagnosis of the Vulvo-Vaginal Stromal Tumors: An Overview.
Review in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 20 citations in OpenAlex.
- Management of a large angiomyofibroblastoma of the vulva: a case report describing radical excision and reconstruction.Case reports in women's health · 2026Article
- Preoperative Arterial Embolization Facilitating Safe Resection of a Hypervascular Aggressive Angiomyxoma: A Case Report.Clinical case reports · 2026Article
- Pararectal aggressive angiomyxoma with bilateral ovarian endometriomas cysts: a rare case report.Frontiers in oncology · 2026Article
- Uterine angiomyofibroblastoma in a domestic cat: A need of precise diagnosis for proper perioperative management.Veterinarni medicina · 2025Article
- Lipoblastoma-like tumor of the inguinal region: a close mimicker of myxoid liposarcoma.Pathologica · 2025Article
- Treatment of Angiomyoblastoma in a Young Lady in Saudi Arabia: A Case Report : Angiomyoblastoma in a Young pLady in Saudi Arabia.Galen medical journal · 2025Article
- A case report and literature review: Diagnosis of pelvic retroperitoneal angiomyofibroblastoma assisted by next-generation sequencing.Frontiers in oncology · 2025Article
- An Unusual Cause of Inguinal Mass in a Patient with Urolithiasis: A Case Report of Deep (Aggressive) Angiomyxoma in a Male Patient.Clinics and practice · 2024Article
- Vulvo-vaginal stromal tumours - Case series of a rare entity from an oncology centre in India.Gynecologic oncology reports · 2024Article
- Pedunculated angiomyofibroblastoma of the vulva.Archives of gynecology and obstetrics · 2024Article
- Angiomyofibroblastoma of the vulva: A case report and review of the literature.Case reports in women's health · 2024Article
- Uterine Cervical Angioleiomyoma Mimicking Squamous Cell Carcinoma.Diagnostics (Basel, Switzerland) · 2023Article
- Aggressive Angiomyxoma of the Lower Female Genital Tract in Pregnancy: A Review of the MITO Rare Tumors Group.Cancers · 2023Review
- A tale of two vulvar angiomyxomas: Two cases and review of literature.Gynecologic oncology reports · 2023Article
- Rare Vulvar Angiomyofibroblastoma: Case Series and Literature Review.International journal of women's health · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe category of the "stromal tumors of the lower female genital tract" encompasses a wide spectrum of lesions with variable heterogeneity, which can be nosologically classified on the basis of their morphologic and immunohistochemical profiles as deep (aggressive) angiomyxoma (DAM), cellular angiofibroma (CAF), angiomyofibroblastoma (AMFB) or myofibroblastoma (MFB). Despite the differential diagnosis between these entities being usually straightforward, their increasingly recognized unusual morphological variants, along with the overlapping morphological and immunohistochemical features among these tumours, may raise serious differential diagnostic problems. METHODS AND
resultsThe data presented in the present paper have been retrieved from the entire published literature on the PubMed website about DAM, CAF, AFMB and MFB from 1984 to 2021. The selected articles are mainly represented by small-series, and, more rarely, single-case reports with unusual clinicopathologic features. The present review focuses on the diagnostic clues of the stromal tumours of the lower female genital tract to achieve a correct classification. The main clinicopathologic features of each single entity, emphasizing their differential diagnostic clues, are discussed and summarized in tables. Representative illustrations, including the unusual morphological variants, of each single tumour are also provided.
conclusionAwareness by pathologists of the wide morphological and immunohistochemical spectrum exhibited by these tumours is crucial to achieve correct diagnoses and to avoid confusion with reactive conditions or other benign or malignant entities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.